Cue Health Inc.

HLTHQ Healthcare Health Information Services

Cue Health Inc.’s revenue for fiscal 2023 (year ended December 2023) was $70.9 million, down 85.3% from fiscal 2022.

0.00 0.00 NaN
Market cap
$6.9M
P/E
0.0×
Fwd P/E
−0.1×
Dividend yield
—
F-score
2/9
Altman Z
−5.66
Beneish M
n/a
Dividend safety
n/a

Insider Decisions last twelve months

Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 26.72%

Capital & Financial Ratios $m

Size
Market Cap 6.90
Revenue ttm 70.94
Net income ttm (373.46)
Free cash flow ttm (157.61)
Net debt Q (81.69)
Valuation
P/E 0.00
Forward P/E (0.05) (negative: loss-making)
Price / sales 0.00
Forward P/S Powerpack
Price / FCF 0.00
Price / book 0.00
Financial health
Current ratio Q 2.54 (at or above 1.5: strong)
Debt / equity Q 0.00 (at or below 0.5: strong)
Interest coverage Q (432.86)
Growth
Revenue growth Q −87.19% (below 0%: shrinking)
Operating income growth Q −285.52% (below 0%: shrinking)
EPS, this year +52.00% (at or above 15%: strong)
EPS, next year A +44.05% (at or above 15%: strong)
Revenue, next year A −17.98% (below 0%: weak)
EPS, past 5 yrs —
EPS, next 5 yrs A —

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/FCF against its own 10 years 93.41%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2020 2021 2022 2023
Cash 128 424 242 82
Receivables 4 105 19 1
Inventory 37 88 82 14
Other 1 7 12 5
184 670 371 110
2020 2021 2022 2023
Payables 24 37 7 8
ST’ Debt 5 — — —
Other — — — —
156 167 71 43

Compound Annual Growth %

10y 5y 3y
Sales — — 45.66%
Cash Flow — — 0.00%
Earnings — — 0.00%
Book Value — — 49.48%

EPS $

Mar Jun Sep Dec Year
’26 — — — — —
’23 (0.62) (0.55) (0.31) (0.96) (2.44)
’22 0.02 (0.67) (0.45) (0.21) (1.31)
’21 0.08 0.14 0.13 0.22 0.59
’20 (0.06) (0.07) (0.52) — (2.90)
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 — — — — —
’23 25 10 17 19 71
’22 179 88 70 147 483
’21 64 137 224 193 618
’20 1 4 5 — 23
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 — — — — —
’23 (54) (43) (13) (29) (138)
’22 32 (52) (40) (52) (112)
’21 (35) (3) 20 9 (9)
’20 (8) (13) (59) 152 93
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 — — — — —
’23 (62) (49) (16) (31) (158)
’22 17 (72) (58) (62) (175)
’21 (67) (30) 0 (29) (125)
’20 (8) (13) (66) 81 15
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 Trend 10 yrs 2024e 2025e 2026e Next 3/yr
Income, $m
Income, $m Revenue — — — — — 7 23 618 483 71 +80.9% 58 106 162 +31.8%
Gross margin, % — — — — — 100.00 34.86 55.26 31.75 (79.16) (179.2) pt
EBT — — — — — (21) (47) 119 (204) (369) +105.7%
EBT margin, % — — — — — (310.99) (206.30) 19.28 (42.15) (519.72) (208.7) pt
Net income — — — 0 — (21) (47) 86 (194) (373) n/m
Per share, $
Per share, $ Revenue — — — — — 0.42 1.41 11.70 3.27 0.46 +2.5%
Earnings — — — — — (1.31) (2.90) 0.63 (1.31) (2.44) +16.9%
Cash flow — — — — — (0.82) 5.68 (0.18) (0.76) (0.90) +2.3%
Capex — — — — — (0.19) (4.79) (2.19) (0.43) (0.13) (8.8%)
Free cash flow — — — — — (1.01) 0.89 (2.37) (1.18) (1.03) +0.5%
Book value — — — — — 0.00 4.59 13.38 3.89 1.64 n/m
Shares, m — — — — — 16 16 53 148 153 +76.5%
Valuation, ×
Valuation, × P/E — — — — — 0.00 0.00 22.16 0.00 0.00 4.4
P/S — — — — — 1.78 1.78 1.15 0.65 0.50 1.2
P/B — — — — — 0.00 0.00 1.00 0.55 0.14 0.3
EV/Sales — — — — — 2.04 2.04 0.47 0.15 (0.65) 0.8
EV/FCF — — — — — (5.24) (5.24) (2.30) (0.42) 0.29 (2.6)
Cash, $m
Cash, $m Operating cash flow — — — — — (13) 93 (9) (112) (138) +80.5%
Capex — — — — — (3) (78) (116) (63) (20) +61.0%
Free cash flow — — — — — (16) 15 (125) (175) (158) +77.3%
Balance, $m
Balance, $m Working capital — — — — — 11 28 503 300 67 +57.9%
Net debt — — — — — (7) (120) (420) (241) (82) +84.3%
Shareholders’ equity — — — — — — 75 707 576 250 +49.5%
Returns, %
Returns, % ROA — — — — — 0.00 (29.94) 5.27 (23.74) (72.21) (72.2) pt
ROIC — — — — — 0.00 0.00 41.52 (38.37) (146.40) (146.4) pt
ROE — — — — — 25.83 59.36 10.94 (30.24) (90.35) (116.2) pt
People
People Employees — — — — — — 1,254 1,585 1,515 726 (16.7%)
Revenue/emp, $m — — — — — 0.00 0.02 0.39 0.32 0.10 n/m
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2023 · latest quarter Dec 2023 · fundamentals updated 26 Oct 2026

Cue Health Inc. vs peers in Health Information Services (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
RNLXY Renalytix plc - Sponsored ADR $17.2M — (loss-making) — +13.73% (above 0%: growing) n/m +17.96% (above 0%: growing) 19.16% (783.91%) Compare
BFRG Bullfrog AI Holdings Inc. $9.1M — (loss-making) — (loss-making) +2,054.00% (above 0%: growing) n/m −5.67% (below 0%: shrinking) 49.63% (658.82%) Compare
HLTHQ Cue Health Inc. $6.9M — (loss-making) — (loss-making) −87.19% (below 0%: shrinking) n/m +50.55% (above 0%: growing) (90.14%) (792.13%)
ACON Aclarion, Inc. $4.5M — (loss-making) — (loss-making) +78.48% (above 0%: growing) n/m −74.22% (below 0%: shrinking) 43.86% (8,164.70%) Compare
MGRX Mangoceuticals, Inc. $4.3M — (loss-making) — −59.07% (below 0%: shrinking) n/m +79.27% (above 0%: growing) 64.24% (1,501.45%) Compare
ZCMD Zhongchao Inc. $4.3M — (loss-making) — +20.44% (above 0%: growing) −550.00% (below 0%: shrinking) +191.85% (above 0%: growing) 41.67% 0.00% Compare
HCTI Healthcare Triangle, Inc. $3.2M 0.0× — (loss-making) +158.38% (above 0%: growing) n/m +67.48% (above 0%: growing) 22.48% (44.28%) Compare
VSEE VSee Health, Inc. $2.8M — (loss-making) — (loss-making) −53.93% (below 0%: shrinking) n/m −257.62% (below 0%: shrinking) 13.20% (172.69%) Compare
WORX SCWorx Corp. $2.0M — (loss-making) — (loss-making) +3.43% (above 0%: growing) n/m +87.99% (above 0%: growing) 46.80% (17.14%) Compare
Median of peers $4.3M — — +17.09% — +42.72% 42.77% (415.75%)

All 44 Health Information Services stocks →

Cue Health Inc. (HLTHQ) Latest News

10 Jun

28 May

Impact 4 · · Business Wire

22 May

Impact 4 · · medtechdive.com

14 May

3 May

Impact 4 · · medtechdive.com

29 Apr

Impact 3 · · Business Wire

18 Mar

15 Mar

16 Feb

9 Feb

Impact 4 · · medtechdive.com

30 Jan

Impact 4 · · Simply Wall St.

9 Nov

8 Nov

25 Oct

6 Oct

Impact 4 · · Business Wire
stockrow.com/HLTHQ · Data as of Oct 26, 2026 · For information only; not investment advice. · © 2026 stockrow.com